Surgery Partners, Inc. $SGRY Shares Sold by Voya Investment Management LLC

Key Points

• Voya Investment Management LLC reduced its stake in Surgery Partners by 31.2%, selling 39,791 shares during the first quarter, now holding 87,916 shares valued at approximately $2.1 million.
• Surgery Partners reported earnings of $0.17 EPS, surpassing analysts' expectations of $0.16 EPS, and experienced an 8.4% revenue increase year-over-year.
• Analysts maintain a consensus rating of "Moderate Buy" for Surgery Partners, with a consensus price target of $32.88 based on multiple research reports.

Voya Investment Management LLC reduced its position in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 31.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 87,916 shares of the company's stock after selling 39,791 shares during the period. Voya Investment Management LLC owned about 0.07% of Surgery Partners worth $2,088,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Surgery Partners by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,678 shares of the company's stock valued at $925,000 after purchasing an additional 1,640 shares during the period. ProShare Advisors LLC grew its holdings in Surgery Partners by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 21,629 shares of the company's stock valued at $458,000 after buying an additional 7,116 shares during the last quarter. State of Wyoming grew its holdings in Surgery Partners by 94.4% in the 4th quarter. State of Wyoming now owns 4,002 shares of the company's stock valued at $85,000 after buying an additional 1,943 shares during the last quarter. Two Sigma Investments LP grew its holdings in shares of Surgery Partners by 93.6% during the 4th quarter. Two Sigma Investments LP now owns 43,338 shares of the company's stock worth $917,000 after purchasing an additional 20,949 shares in the last quarter. Finally, Mackenzie Financial Corp boosted its stake in Surgery Partners by 2.8% in the 4th quarter. Mackenzie Financial Corp now owns 21,974 shares of the company's stock valued at $465,000 after buying an additional 599 shares in the last quarter.

Surgery Partners Price Performance

Shares of SGRY stock traded up $0.25 on Monday, reaching $21.87. The company's stock had a trading volume of 1,257,326 shares, compared to its average volume of 1,280,199. The company has a quick ratio of 1.78, a current ratio of 1.93 and a debt-to-equity ratio of 1.10. Surgery Partners, Inc. has a 12-month low of $18.87 and a 12-month high of $33.37. The company has a market capitalization of $2.80 billion, a P/E ratio of 34.87 and a beta of 1.76. The stock's 50 day simple moving average is $22.39 and its 200-day simple moving average is $22.45.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.01. The firm had revenue of $826.20 million for the quarter, compared to analysts' expectations of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%.The company's revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the firm earned $0.21 earnings per share. As a group, equities analysts predict that Surgery Partners, Inc. will post 0.67 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently commented on SGRY. Barclays dropped their price objective on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating for the company in a report on Tuesday, May 27th. Bank of America assumed coverage on Surgery Partners in a research report on Monday, July 28th. They issued a "buy" rating and a $28.00 price objective for the company. Finally, JPMorgan Chase & Co. started coverage on Surgery Partners in a report on Thursday. They issued a "neutral" rating and a $27.00 price objective for the company. Six equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, Surgery Partners presently has a consensus rating of "Moderate Buy" and an average price target of $32.88.

Insider Buying and Selling at Surgery Partners

In other Surgery Partners news, insider Harrison R. Bane sold 9,339 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $22.48, for a total transaction of $209,940.72. Following the completion of the transaction, the insider owned 117,181 shares of the company's stock, valued at $2,634,228.88. This represents a 7.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Teresa Deluca sold 20,018 shares of the stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the sale, the director directly owned 45,173 shares in the company, valued at $1,027,234.02. This trade represents a 30.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.70% of the company's stock.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.